Dr. John Paul Waymack – MD, ScD
Dr. Waymack has served as Chairman of the Board since July 2013. Dr. Waymack brings to Kitov over 20 years' experience in the biopharma field. A former academic transplant surgeon and FDA medical officer, he has over 20 years' experience as a drug development consultant for major pharmaceutical companies, including Pfizer, Roche, Pharmacia, Warner Lambert and Searle. During his 10-year academic career, Dr. Waymack published over 100 scientific essays, mainly in the fields of prostaglandins and immunology. In addition, he was commissioned and served as a Major in the US Army Medical Corps in the position of Chief of Surgical Research at the Institute for Surgical Research. Dr. Waymack was also an Associate Professor of Surgery at the University of Texas Medical Branch and at the University of Medicine and Dentistry of New Jersey.
Mr. Israel has served as a member of the Board since October 2012. Prior to joining Kitov, Mr. Israel served as Vice President - Business Development at Capital Point (TASE: CPTP). Before that, Mr. Israel was the founding CEO of Uneri Capital, a consulting firm in the capital markets field specializing in the healthcare sector, from 2008 until 2011. Prior to that, Mr. Israel was the founding CEO of BeeContact (formerly TASE: BCNT), from 2001 until 2007. Mr. Israel also serves as the Chairman of the Board of NextGen BioMed (TASE: NXGN), and as a board member for various private healthcare corporations.
Simcha Rock – CPA, MBA
Mr. Rock has served as a member of the Board since July 2013. Prior to joining Kitov, Mr. Rock was a private equity manager at Edmond de Rothschild Private Equity Management, a firm specializing in the management of venture capital and other private equity investment funds, from 2000 until 2011. In that capacity, he was responsible for all financial, legal and administrative matters for several investment funds. Before that, Mr. Rock held financial management positions at Intel Electronics, The Jerusalem College of Technology, and JC Technologies.
Ido Agmon - MBA
Mr. Agmon has served as a member of our board since June 2016. Mr. Agmon is a manager of Aviv New-Tech, a private investment fund which manages a portfolio of public Israeli & global biomed and technology companies and also acts as an independent consultant, providing start-ups and technology-based ventures with advice in strategic planning and fund-raising. He previously served as the CEO of Meytav Technology Incubator, an Israeli-based accelerator for biotech, pharma & medtech ventures with over 20 portfolio companies. Mr. Agmon has served as a board member at a number of biomed ventures. He worked as the Director of Business Development in ATI incubator, a technology incubator specializing in biomed and cleantech projects, responsible for deal-flow and project evaluation. Mr. Agmon holds a Bachelor’s Degree in Business Administration & Life Sciences from Tel Aviv University, Tel Aviv, Israel, and an MBA from The Hebrew University, Jerusalem, Israel.
Mr. Steinberg has served as a member of our board since July 2016. Mr. Steinberg is the chief financial officer of Glide Talk Ltd., a technology company in the video messaging arena. He previously served as vice president, finance at ClientConnect Ltd., a subsidiary of Conduit Ltd., and subsequent to an acquisition. Mr. Steinberg has provided start-ups and as well as mature organizations with advice in financial reporting, due diligence and business models, and was employed by Answers Corporation, a NASDAQ listed company, where he served as chief financial officer. He has held a number of finance and chief financial officer roles, following a ten year period of service as an audit manager at Coopers & Lybrand (currently Price Waterhouse Coopers) in New York City. Mr. Steinberg holds a Bachelor’s Degree in Business Administration from Florida International University – School of Business Administration, and was granted a CPA license in New York State.